secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0000950170-25-105037
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q2 revenue $60.8M (-5% YoY); raises FY revenue guidance bottom by $3M
--------------------------------------------------------------------------------

- Q2 net loss $(9.3)M vs $(306.2)M (prior year included $363.6M goodwill impairment).
- Adjusted net income $9.7M, down from $14.2M in Q2 2024; adjusted EBITDA $18.7M (31% margin).
- Q3 2025 revenue guidance $59-60M; FY 2025 raised to $237-240M from $234-240M.
- Adjusted net income per diluted share for Q3 guided at $0.05-0.06; FY at $0.22-0.23.
- Customer wins include a revenue cycle management firm and a digital health org returning after non-renewal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017025105037/0000950170-25-105037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017025105037/dh-20250807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-105037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer